Unveiling a New Level of Precision: Discover The Enhanced Prolaris Test Now

Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Corporate Headquarters
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
        • EMR Integrations
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Corporate Headquarters
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Urology

Urology
  • Category
    • All
    • Patient Blog
    • Patient-Featured
    • Patients
    • Physician Blog
    • Prostate Cancer
    • Provider Blog
    • Providers
    • Urology
    • Video

Navigating the Prostate Cancer Screening Process: Questions to Ask Your Urologist

September 22, 2023

Geoff McLennan, MPA, Prostate Cancer Patient and Advocate How is prostate cancer (PCa) detected? You or a male relative or friend just got a high PSA te...

Continue Reading

This biomarker test is defining shared decision-making in celebration of Prostate Cancer Awareness Month

September 15, 2023

While androgen deprivation therapy (ADT) is effective at slowing the progression of prostate cancer by suppressing androgen production, it is often associated ...

Continue Reading

Prostate Cancer Awareness Month 2023

September 15, 2023

Geoff McLennan, MPA, Prostate Cancer Patient and Advocate Men and their families should be aware of prostate cancer (PCa), as roughly 300,000 men are diagn...

Continue Reading

Living with Prostate Cancer – How to Cope and Seek Support for a Healthy Lifestyle

August 18, 2023

Geoff McLennan, MPA, Prostate Cancer Patient and Advocate - August 2023 One of my hardest days was when my urologist told me I had prostate cancer. For thos...

Continue Reading

Exploring the Components and Utility of a Full Workup for Newly Diagnosed Prostate Cancer Patients

July 28, 2023

https://myriad-1.wistia.com/medias/z6zrgjhd4m We gathered a distinguished panel of experts, including Dr. Neal Shore, Dr. Ben Lowentritt, Dr. Ted Schaefer...

Continue Reading

Biomarker Testing: Empowering Patients in Prostate Cancer Management

July 14, 2023

Geoff McLennan, MPA, Prostate Cancer Patient and Advocate - July 2023 Welcome back to my blog series on helping patients understand prostate cancer. I hope ...

Continue Reading

Uncovering Genetic Abnormalities: A Prostate Cancer Patient’s Journey to Personalized Treatment

June 27, 2023

https://myriad-1.wistia.com/medias/1x6w5p6mip In the field of Urology, every patient's journey is unique, and sometimes, the unexpected can unfold. Kara C...

Continue Reading

Empowered by Genetic Testing: How MyRisk® Hereditary Cancer Testing Helps Take Preventive Measures

May 25, 2023

Larry underwent a radical prostatectomy when he was first diagnosed with prostate cancer at age 62. Although the surgery was successful in removing the cancer,...

Continue Reading
A prostate cancer patient and his supportive son

Detecting more prostate cancer earlier with PSMA PET Scans

May 24, 2023

Prostate cancer doesn't always require aggressive treatment. Most men can delay complex treatment until necessary through Active Surveillance according to a ne...

Continue Reading

Understanding Prostate Cancer: A Guide for Men and Their Loved Ones

May 1, 2023

Prostate cancer is a very common disease, roughly 1 in 8 American men will be diagnosed with prostate cancer during their lifetime. Receiving a prostate cancer...

Continue Reading

Healthcare Hero: Kara Cossis, Chesapeake Urology

April 12, 2023

At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a...

Continue Reading

Medical Experts Discuss Benefits of Genetic Testing in Prostate Cancer Care

March 23, 2023

In a recent Myriad Live webinar, our Chief Medical Officer, Thomas Slavin, hosted a lively conversation about prostate cancer with two experts from the field: ...

Continue Reading

Prostate Cancer Proactive Healthcare Steps

March 17, 2023

Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about...

Continue Reading

Expanding access to PARP inhibitors in prostate cancer treatment

March 14, 2023

Last month, Myriad attended the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU) to connect with researchers and doctors around emergent and controversial a...

Continue Reading

Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test

March 10, 2023

Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Notice
  • HIPAA Notice of Privacy Practices
  • Patents
  • Code of Conduct
  • Supplier Code of Conduct
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.™

  • © 2023 Myriad Genetics, Inc.

Locations

United States
Europe
Japan